6. Parkinson disease Clinical trials / Disease details
Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01143454 (ClinicalTrials.gov) | July 21, 2010 | 11/6/2010 | Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System | Cardiovascular Disease Discovery Protocol | Cardiomyopathy;Li-Fraumeni Syndrome;Parkinson's Disease;Atherosclerosis;Cardiovascular Capacity | Drug: 11C-Acetate;Drug: 13N-Amonia | National Heart, Lung, and Blood Institute (NHLBI) | NULL | Recruiting | 1 Year | 100 Years | All | 5000 | United States |